Table 1.
Table 1A | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Canonical | Canonical | Canonical | Canonical | Canonical | Caspase1 | Caspase1 | Caspase1 | Caspase4 | Caspase4 | Exosomes | Exosome | |
Specific | Caspase1 | Caspase4 | Exosomes | WPB | Specific | Caspase4 | Exosomes | Specific | Exosomes | Specific | WPB | |
Actin filament based process | 1 | |||||||||||
Regulated exocytosis | 1 | 1 | 1 | 1 | ||||||||
Hemostasis | 1 | |||||||||||
Signaling by Receptor Tyrosine Kinases | 1 | |||||||||||
Organelle localization | 1 | |||||||||||
Cell morphogenesis involved in differentiation | 1 | |||||||||||
Regulation of cell adhesion | 1 | 1 | ||||||||||
Adaptive immune system | 1 | 1 | ||||||||||
Membrane Trafficking | 1 | |||||||||||
Cellular response to nitrogen compound | 1 | |||||||||||
DNA conformation change | 1 | |||||||||||
Cell substrate adherens junction assembly | 1 | |||||||||||
Regulation of mRNA metabolic process | 1 | |||||||||||
Detoxification of ROS | 1 | |||||||||||
Orc1 removal from chromatin | 1 | |||||||||||
Disease of signal transduction by growth factor receptors and second messengers | 1 | |||||||||||
Stem cell differentiation | 1 | |||||||||||
establishment of protein localization to endoplasmic reticulum | 1 | |||||||||||
Cellular response to abiotic stimulus | 1 | |||||||||||
actomyosin structure organization | 1 | |||||||||||
Leukocyte degranulation | 1 | |||||||||||
Endocytosis | 1 | |||||||||||
RHO GTPase Effectors | 1 | |||||||||||
Golgi vesicle transport | 1 | |||||||||||
positive regulation of organelle organization | 1 | 1 | ||||||||||
phagocytosis | 1 | |||||||||||
Establishment of organelle localization | 1 | |||||||||||
regulation of leukocyte activation | 1 | |||||||||||
cytosolic transport | 1 |
Table 1B | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Canonical | Canonical | Canonical | Canonical | Canonical | Caspase1 | Caspase1 | Caspase1 | Caspase4 | Caspase4 | Exosomes | Exosome | |
Specific | Caspase1 | Caspase4 | Exosomes | WPB | Specific | Caspase4 | Exosomes | Specific | Exosomes | Specific | WPB | |
NABA matrisome associated | 1 | 1 | ||||||||||
extracellular structure organization | 1 | 1 | ||||||||||
NABA core matrisome | 1 | |||||||||||
humoral immune response | 1 | 1 | ||||||||||
complement and coagulation cascades | 1 | |||||||||||
NABA secreted factors | 1 | |||||||||||
negative regulation of proteolysis | 1 | |||||||||||
regulation of IGF transport and uptake by IGFBPs | 1 | |||||||||||
response to wounding | 1 | |||||||||||
Cell surface interactions at the vascular wall | 1 | |||||||||||
Peptidyl tyrosine phosphorylation | 1 | |||||||||||
negative regulation of supramolecular fiber organization | 1 | |||||||||||
transcription of the HIV genome | 1 | |||||||||||
oxidative phosphorylation | 1 | |||||||||||
CDC5L complex | 1 | |||||||||||
mRNA catabolic process | 1 | |||||||||||
chaperone mediated protein transport | 1 | |||||||||||
positive regulation of viral process | 1 | |||||||||||
NABA ECM Glycoproteins | 1 | |||||||||||
Cell-cell communication | 1 | |||||||||||
Interconversion of nucleotide di-and triphosphates | 1 | |||||||||||
organic cyclic compound catabolic process | 1 | |||||||||||
carbon metabolism | 1 | |||||||||||
protein folding | 1 | |||||||||||
IL12 mediated signaling pathway | 1 | |||||||||||
HIF-1 signaling pathway | 1 | |||||||||||
pentose phosphate metabolism | 1 | |||||||||||
establishment of protein localization to organelle | 1 | |||||||||||
cellular response to oxidative stress | 1 |
Table 1C | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Canonical | Canonical | Canonical | Canonical | Canonical | Caspase1 | Caspase1 | Caspase1 | Caspase4 | Caspase4 | Exosomes | Exosome | |
Specific | Caspase1 | Caspase4 | Exosomes | WPB | Specific | Caspase4 | Exosomes | Specific | Exosomes | Specific | WPB | |
Defective EXT2 causes exostoses 2 | 1 | |||||||||||
cell substrate adhesion | 1 | |||||||||||
VEGFA VEGFR2 signaling pathway | 1 | |||||||||||
positive regulation of cytokine production | 1 | |||||||||||
chemotaxis | 1 | 1 | ||||||||||
small molecule catabolic process | 1 | |||||||||||
aromatic compound catabolic process | 1 | |||||||||||
cofactor metabolic process | 1 | |||||||||||
oxidation reduction process | 1 | |||||||||||
alpha amino acid metabolic process | 1 | |||||||||||
cysteine and methionine metabolism | 1 | |||||||||||
platelet degranulation | 1 | |||||||||||
drug catabolic process | 1 | |||||||||||
purine ribonucleoside metabolic process | 1 | |||||||||||
myeloid leukocyte activation | 1 | |||||||||||
positice regulation by host of viral process | 1 | |||||||||||
regulation of endothelial cell proliferation | 1 | |||||||||||
carbohydrate derivative catabolic process | 1 | |||||||||||
intermembrane lipid transfer | 1 | |||||||||||
fatty acid derivative biodynthetic process | 1 | |||||||||||
metabolism of vitamins and cofactors | 1 | |||||||||||
rhythmic process | 1 | |||||||||||
response to virus | 1 | |||||||||||
Cytokine-cytokine receptor interaction | 1 | |||||||||||
defense response to other organism | 1 | |||||||||||
GPCR ligand binding | 1 | |||||||||||
PI3K-akt signaling pathway | 1 | |||||||||||
glycoprotein metabolic process | 1 | |||||||||||
skeletal system development | 1 | |||||||||||
aminoglycan metabolic process | 1 | |||||||||||
response to unfolded protein | 1 |
The signal pathways of the gene list from Figure 1B with 12 groups were analyzed by Metascape (https://metascape.org/gp/index.html#/main/step1).